ROZANOLIXIZUMAB vs RUXOLITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ROZANOLIXIZUMAB vs RUXOLITINIB: Safety Overview
| Metric | ROZANOLIXIZUMAB | RUXOLITINIB |
|---|---|---|
| Total FAERS Reports | 303 | 68,133 |
| Deaths Reported | 9 | 10,908 |
| Death Rate | 3.0% | 16.0% |
| Hospitalizations | 114 | 14,461 |
| Average Patient Age | 61.3 yrs | 59.7 yrs |
| % Female Patients | 60.9% | 48.8% |
| FDA Approval Date | N/A | Nov 16, 2011 |
| Manufacturer | UCB, Inc. | Incyte Corporation |
| Route | SUBCUTANEOUS | TOPICAL |
| Marketing Status | N/A | Prescription |